Atreya Dash

Atreya Dash

University of Washington

H-index: 33

North America-United States

About Atreya Dash

Atreya Dash, With an exceptional h-index of 33 and a recent h-index of 23 (since 2020), a distinguished researcher at University of Washington, specializes in the field of Urology.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance

Abstract B048: Performance of diagnostic biomarkers in the Canary Prostate cancer Active Surveillance Study (PASS)

A phase 1/2 study of rapamycin and cisplatin/gemcitabine for treatment of patients with muscle-invasive bladder cancer

Dietary patterns and risk of Gleason grade progression among men on active surveillance for prostate cancer: results from the Canary Prostate Active Surveillance Study

PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)

Whole‐body and adipose tissue metabolic phenotype in cancer patients

Evaluating the outcomes of active surveillance in grade group 2 prostate cancer: prospective results from the Canary PASS cohort

Comparison of robot-assisted and open radical cystectomy in recovery of patient-reported and performance-related measures of independence: a secondary analysis of a randomized …

Atreya Dash Information

University

Position

___

Citations(all)

4817

Citations(since 2020)

2167

Cited By

3537

hIndex(all)

33

hIndex(since 2020)

23

i10Index(all)

61

i10Index(since 2020)

42

Email

University Profile Page

Google Scholar

Atreya Dash Skills & Research Interests

Urology

Top articles of Atreya Dash

The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance

Cancer

2024/2/14

Colm Morrissey
Colm Morrissey

H-Index: 37

Atreya Dash
Atreya Dash

H-Index: 21

Abstract B048: Performance of diagnostic biomarkers in the Canary Prostate cancer Active Surveillance Study (PASS)

Cancer Research

2023/6/2

Menghan Liu
Menghan Liu

H-Index: 7

Atreya Dash
Atreya Dash

H-Index: 21

A phase 1/2 study of rapamycin and cisplatin/gemcitabine for treatment of patients with muscle-invasive bladder cancer

Clinical Genitourinary Cancer

2023/4/1

Dietary patterns and risk of Gleason grade progression among men on active surveillance for prostate cancer: results from the Canary Prostate Active Surveillance Study

Nutrition and cancer

2023/2/7

Menghan Liu
Menghan Liu

H-Index: 7

Atreya Dash
Atreya Dash

H-Index: 21

PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)

The Journal of Urology

2022/5

Whole‐body and adipose tissue metabolic phenotype in cancer patients

Journal of cachexia, sarcopenia and muscle

2022/4

Evaluating the outcomes of active surveillance in grade group 2 prostate cancer: prospective results from the Canary PASS cohort

The Journal of urology

2022/4

Comparison of robot-assisted and open radical cystectomy in recovery of patient-reported and performance-related measures of independence: a secondary analysis of a randomized …

JAMA network Open

2022/2/1

Atreya Dash
Atreya Dash

H-Index: 21

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer

2022

Atreya Dash
Atreya Dash

H-Index: 21

Impact of Prostate Health Index results for prediction of biopsy grade reclassification during active surveillance

The Journal of urology

2022/11

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine

2022/11

Atreya Dash
Atreya Dash

H-Index: 21

[68Ga]-PSMA-11 can clarify equivocal lesions on conventional imaging and change management decisions among men with previously treated prostate cancer

2022/6/1

Clinical impact of PSMA PET in patients with biochemically recurrent prostate cancer after locoregional definitive therapy.

2022/6/1

Work-Related Pain and Ergonomics Education Among Urologists: A Survey Study

Age (mean, sd)

2022/5/1

Weight loss in cancer patients correlates with p38β MAPK activation in skeletal muscle

Frontiers in Cell and Developmental Biology

2021/12/7

Effect of diagnostic biopsy practice location on grade/volume reclassification in active surveillance for prostate cancer: a multicenter analysis from the canary PASS cohort

Urology Practice

2021/9

Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients

Clinical nutrition

2021/3/1

Social and clinical correlates of neoadjuvant chemotherapy in medicare beneficiaries with muscle invasive bladder cancer from 2004-2015

Urology

2021/3/1

Atreya Dash
Atreya Dash

H-Index: 21

George R Schade
George R Schade

H-Index: 12

Tailoring intensity of active surveillance for low-risk prostate cancer based on individualized prediction of risk stability

JAMA oncology

2020/10/1

Atreya Dash
Atreya Dash

H-Index: 21

Health related quality of life of patients with bladder cancer in the RAZOR trial: a multi-institutional randomized trial comparing robot versus open radical cystectomy

The Journal of urology

2020/9

Atreya Dash
Atreya Dash

H-Index: 21

See List of Professors in Atreya Dash University(University of Washington)

Co-Authors

academic-engine